Halozyme Therapeutics

ISIN US40637H1095

 | 

Code du titre A0DLHS

Cap. boursière (en EUR)
6,465 m
Country
United States
Secteur
Healthcare
Rendement en dividendes
0.00%
 

Aperçu

Description

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Afficher plus Afficher moins
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Données financières

Indicateurs clés

Capitalisation boursière, EUR 6,465 m
BPA, EUR 2.21
Ratio cours/valeur comptable 154.1
PER 25.0
Rendement en dividendes 0.00%

Income statement (2025)

Chiffre d'affaires, EUR 1,238 m
Résultat net, EUR 281 m
Marge bénéficiaire 22.69%

What ETF is Halozyme Therapeutics in?

There are 4 ETFs which contain Halozyme Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Halozyme Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Poids Objectif d'investissement Taille fonds en M €
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.61%
Equity
United States
Health Care
Biotech
46
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
508
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.13%
Equity
United States
Small Cap
204
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.